Table 1 Selected demographic and baseline characteristics of the patients

All patients, No. (%)

123 (100)

Sex, No. (%)

  Female

120 (98)

  Male

3 (2)

Race

  African American

48 (39)

  Caucasian

5 (4)

  Other

70 (57)

Age (in years) at diagnosis, median [range]

53 [32–78]

Hormone receptor expression status, No. (%)

  ER+

81 (66)

  PR+

67 (54)

  HER2/neu overexpressed

16 (13)

Medical comorbidities, No. (%)

  DM

20 (16)

  HIV

3 (2)

  Alcohol abuse

5 (4)

  Pre-existing peripheral neuropathy

4 (3)

Taxane received, No (%)

  Paclitaxel only

46 (37)

  Docetaxel only

70 (57)

  Multiple agents

7 (6)

Total patients needing dose reduction, No. (%)

49 (40)

  CIPN

21 (17)

  Other causes

28 (24)